Leukeran Articles
Genmab plans to initiate four ofatumumab studies
1 September 2008
FDA clears Cephalon's Treanda for CLL
31 March 2008
Bayer's MabCampath cleared for CLL by EC
14 January 2008
CHMP advocates MabCampath approval
29 October 2007
FDA approves Campath as single agent for B-CLL
1 October 2007
Cephalon plans to file Treanda NDA in 3rd qtr
9 July 2007
Fludara cleared for first-line use in CLL
17 February 2003
M&I's MabCampath is approved by EMEA
12 July 2001
MabCampath nears EU approval for CLL
30 March 2001
Clinical Trial News In Brief
28 May 1998
LeukoSite Lead Product May Be On Market By 2000
28 May 1998
Sandoz MDR Drug Shows Promise In Early Trials
13 November 1995
COMPANIES HAVE SAY IN UK NHS DRUG ENQUIRY
14 February 1994
NOVEL TREATMENT FOR BREAST CANCER
2 November 1992
Showing 1-15 of 15 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
